Market Size of Cell Counting Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.20 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Cell Counting Market Analysis
Over the next few years, the cell counting market is expected to register a CAGR of 7.2%.
COVID-19 had a significant impact on the adoption of cell-counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia were the potential indicators of COVID-19. The study, published in BMC Infectious Diseases in June 2021, found that in COVID-19 patients, a high WBC count upon admission was significantly linked to death. As a result, in the therapy of COVID-19, a higher WBC count should be given more consideration. Thus, the COVID-19 pandemic had a pronounced impact on the growth of the market. However, as the pandemic has subsided currently, the market is expected to experience stable growth over the forecast period of the study.
The major factors contributing to the market's growth are the rising incidence of target diseases like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders; and the growing use of high-throughput flow cytometry and automated hematology analyzers.
According to the data from UNAIDS, in 2022, an estimated 38.4 million people worldwide were living with HIV, and an estimated 1.5 million people became newly infected with HIV in 2021. It was also stated that by 2021, 28.7 million people would have access to antiretroviral therapy. Thus, rising cases of infectious diseases are ultimately expected to increase the demand for cell counting products and consumables.
Furthermore, technological advancements in cell counting products and consumables have led to increased product launches and, thereby, increased adoption, in turn driving market growth. For instance, Logos Biosystems, a leading provider of cutting-edge life science solutions and a division of Aligned Genetics, Inc., officially launched the CountWire System in February 2021.
Therefore, the rising prevalence of chronic diseases, growing technological advancements, and product launches in the cell counting market, among others, are expected to drive the growth of this market. But the growth of the market is likely to be slowed by the high cost of advanced cell counting systems and product recalls of hematology analyzers.
Cell Counting Industry Segmentation
As per the scope of the report, cell counting plays a vital role in cell analysis; it helps identify the viability of cells and cell growth; and it quantifies the number of live or dead cells in cell culture. The Cell Counting market is segmented by Product Type (Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, and Cell Counters) and Consumables (Media, Sera, and Reagents, Assay Kits, and Other Consumables)) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | ||||||
| ||||||
|
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cell Counting Market Size Summary
The cell counting market is poised for steady growth, driven by the increasing prevalence of chronic and infectious diseases, alongside technological advancements in cell counting devices. The COVID-19 pandemic significantly accelerated the adoption of cell counting products, as they became crucial in monitoring indicators like lymphopenia and WBC counts in patients. As the pandemic's impact wanes, the market is expected to stabilize and continue expanding. Key factors propelling market growth include the rising incidence of diseases such as HIV and cancer, and the growing utilization of high-throughput flow cytometry and automated hematology analyzers. Technological innovations and new product launches, such as those by Logos Biosystems and CytoSMART Technologies, further contribute to market expansion, despite challenges like high costs and product recalls.
The instruments segment of the cell counting market is anticipated to maintain a significant share due to its increasing application in research fields like cancer biology, immunology, and neuroscience. The demand for advanced cell counting devices is bolstered by initiatives from major market players and the rising prevalence of cancer, particularly in North America. The region's market dominance is attributed to a high patient population, extensive healthcare infrastructure, and active research and development activities. Companies like BD and Mindray are driving growth through new product introductions. The competitive landscape is characterized by strategic moves such as partnerships and acquisitions, with key players including Danaher Corporation, Thermo Fisher Scientific, and GE Healthcare leading the market.
Cell Counting Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Incidence of Target Diseases and Blood Disorders
-
1.2.2 Growing Use of High-throughput Flow Cytometry and Automated Hematology Analyzers
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Advanced Cell Counting Systems and Product Recalls of Hematology Analyzers
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Instruments
-
2.1.1.1 Spectrophotometers
-
2.1.1.2 Flow Cytometers
-
2.1.1.3 Hematology Analyzers
-
2.1.1.4 Cell Counters
-
-
2.1.2 Consumables
-
2.1.2.1 Media, Sera, and Reagents
-
2.1.2.2 Assay Kits
-
2.1.2.3 Other Consumables
-
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Cell Counting Market Size FAQs
What is the current Cell Counting Market size?
The Cell Counting Market is projected to register a CAGR of 7.20% during the forecast period (2024-2029)
Who are the key players in Cell Counting Market?
Thermo Fisher Scientific, Becton, Dickinson and Company, Bio-Rad Laboratories, Merck KGaA and Danaher Corporation (Beckman Coulter, Inc.) are the major companies operating in the Cell Counting Market.
